{"success":true,"data":{"pressRelease":{"id":"154592","rtpr_id":"nBw3JBfRpa-20260928","ticker":"ANGO","exchange":"NASDAQ","all_tickers":["ANGO"],"title":"AngioDynamics to Report Fiscal 2027 First Quarter Results on October 8, 2026","author":"Business Wire","published_at":"2026-09-28T20:30:00.292Z","article_body":"AngioDynamics to Report Fiscal 2027 First Quarter Results on October 8, 2026\n\nAngioDynamics, Inc. (NASDAQ: ANGO), a medical technology company focused on\nrestoring healthy blood flow in the body's vascular system, expanding cancer\ntreatment options and improving patient quality of life, today announced that\nit will report financial results for the first quarter of fiscal year 2027\nbefore the market open on Thursday, October 8, 2026. The Company’s\nmanagement will host a conference call at 8:00 am ET the same day to discuss\nthe results.\n\nTo participate in the conference call, dial 1-877-407-0784 (domestic) or\n+1-201-689-8560 (international). This conference call will also be webcast and\ncan be accessed from the “Investors” section of the AngioDynamics website\nat www.angiodynamics.com\n(https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.angiodynamics.com&esheet=54612310&newsitemid=20260928483745&lan=en-US&anchor=www.angiodynamics.com&index=1&md5=09d2b15783681cd5769d03ee156c3264)\n. The webcast replay of the call will be available at the same site\napproximately one hour after the end of the call.\n\nA recording of the call will also be available, until Thursday, October 15,\n2026, 2026 at 11:59 PM ET. To hear this recording, dial 1-844-512-2921\n(domestic) or +1-412-317-6671 (international) and enter the passcode 13762341.\n\nAbout AngioDynamics, Inc.\n\nAngioDynamics is a leading and transformative medical technology company\nfocused on restoring healthy blood flow in the body’s vascular system,\nexpanding cancer treatment options and improving patient quality of life.\n\nThe Company’s innovative technologies and devices are chosen by talented\nphysicians in fast-growing healthcare markets to treat unmet patient needs.\nFor more information, visit www.angiodynamics.com\n(https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.angiodynamics.com&esheet=54612310&newsitemid=20260928483745&lan=en-US&anchor=www.angiodynamics.com&index=2&md5=372749bb37b9e2b8c8d4234a7b0f1dcb)\n.\n\n\n\nView source version on businesswire.com:\nhttps://www.businesswire.com/news/home/20260928483745/en/\n(https://www.businesswire.com/news/home/20260928483745/en/)\n\nInvestors:\n\nStephen Trowbridge\n\nExecutive Vice President & CFO\n\n518-795-1408\n\nstrowbridge@angiodynamics.com \n(mailto:strowbridge@angiodynamics.com) \n\n\nMedia:\n\nSaleem Cheeks\n\nVice President, Communications\n\n518-795-1174\n\nscheeks@angiodynamics.com (mailto:scheeks@angiodynamics.com)\n\n\nCopyright Business Wire 2026","article_body_html":"","raw_payload":{"data":{"id":"nBw3JBfRpa-20260928","title":"AngioDynamics to Report Fiscal 2027 First Quarter Results on October 8, 2026","author":"Business Wire","ticker":"ANGO","created":"2026-09-28T20:30:00.292Z","tickers":["ANGO"],"exchange":"NASDAQ","article_body":"AngioDynamics to Report Fiscal 2027 First Quarter Results on October 8, 2026\n\nAngioDynamics, Inc. (NASDAQ: ANGO), a medical technology company focused on\nrestoring healthy blood flow in the body's vascular system, expanding cancer\ntreatment options and improving patient quality of life, today announced that\nit will report financial results for the first quarter of fiscal year 2027\nbefore the market open on Thursday, October 8, 2026. The Company’s\nmanagement will host a conference call at 8:00 am ET the same day to discuss\nthe results.\n\nTo participate in the conference call, dial 1-877-407-0784 (domestic) or\n+1-201-689-8560 (international). This conference call will also be webcast and\ncan be accessed from the “Investors” section of the AngioDynamics website\nat www.angiodynamics.com\n(https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.angiodynamics.com&esheet=54612310&newsitemid=20260928483745&lan=en-US&anchor=www.angiodynamics.com&index=1&md5=09d2b15783681cd5769d03ee156c3264)\n. The webcast replay of the call will be available at the same site\napproximately one hour after the end of the call.\n\nA recording of the call will also be available, until Thursday, October 15,\n2026, 2026 at 11:59 PM ET. To hear this recording, dial 1-844-512-2921\n(domestic) or +1-412-317-6671 (international) and enter the passcode 13762341.\n\nAbout AngioDynamics, Inc.\n\nAngioDynamics is a leading and transformative medical technology company\nfocused on restoring healthy blood flow in the body’s vascular system,\nexpanding cancer treatment options and improving patient quality of life.\n\nThe Company’s innovative technologies and devices are chosen by talented\nphysicians in fast-growing healthcare markets to treat unmet patient needs.\nFor more information, visit www.angiodynamics.com\n(https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.angiodynamics.com&esheet=54612310&newsitemid=20260928483745&lan=en-US&anchor=www.angiodynamics.com&index=2&md5=372749bb37b9e2b8c8d4234a7b0f1dcb)\n.\n\n\n\nView source version on businesswire.com:\nhttps://www.businesswire.com/news/home/20260928483745/en/\n(https://www.businesswire.com/news/home/20260928483745/en/)\n\nInvestors:\n\nStephen Trowbridge\n\nExecutive Vice President & CFO\n\n518-795-1408\n\nstrowbridge@angiodynamics.com \n(mailto:strowbridge@angiodynamics.com) \n\n\nMedia:\n\nSaleem Cheeks\n\nVice President, Communications\n\n518-795-1174\n\nscheeks@angiodynamics.com (mailto:scheeks@angiodynamics.com)\n\n\nCopyright Business Wire 2026"},"type":"article","timestamp":"2026-09-28T20:30:00.339211598Z","server_sent_at_ms":1790627400339},"received_at":"2026-09-28T20:30:00.586Z","source_url":"https://www.businesswire.com/news/home/20260928483745/en/"},"analysis":{"id":"143342","press_release_id":"154592","analysis_json":{"industry":{"label":"Health Care Equipment & Supplies","sector":"Health Care"},"redFlags":[],"eventType":"other","narrative":"AngioDynamics will report fiscal 2027 first-quarter results before market open on Thursday, October 8, 2026.\n\nManagement will host a conference call at 8:00 am ET the same day, with a webcast available in the Investors section of the company website and a replay until October 15, 2026.\n\nThis is a scheduling notice only; no financial figures or guidance were disclosed.","sentiment":"neutral","agentHooks":{"shouldPost":false,"suggestedAngle":"Calendar notice -- mark Q1 FY27 earnings for October 8, 2026 premarket."},"keyFigures":{},"namedEntities":{"people":[{"name":"Stephen Trowbridge","role":"Executive Vice President & CFO"},{"name":"Saleem Cheeks","role":"Vice President, Communications"}],"products":[],"companies":[{"name":"AngioDynamics, Inc.","ticker":"ANGO"}],"dollarAmounts":[]},"materialImpact":{"score":1,"reasoning":"Boilerplate earnings-date announcement with no financial results, guidance, or other substantive disclosures."},"tickerRelevance":{"others":[],"primary":"ANGO"},"globalImportance":8,"audienceRelevance":10,"eventTypeSecondary":[],"importanceComponents":{"tickerTier":"small-cap","eventGravity":"earnings-date-announcement","informationalContent":"none"}},"event_type":"other","event_type_secondary":null,"sentiment":"neutral","material_impact_score":1,"narrative":"AngioDynamics will report fiscal 2027 first-quarter results before market open on Thursday, October 8, 2026.\n\nManagement will host a conference call at 8:00 am ET the same day, with a webcast available in the Investors section of the company website and a replay until October 15, 2026.\n\nThis is a scheduling notice only; no financial figures or guidance were disclosed.","key_figures":{},"named_entities":{"people":[{"name":"Stephen Trowbridge","role":"Executive Vice President & CFO"},{"name":"Saleem Cheeks","role":"Vice President, Communications"}],"products":[],"companies":[{"name":"AngioDynamics, Inc.","ticker":"ANGO"}],"dollarAmounts":[]},"model_name":"glm-5.3-flashx","prompt_hash":"sha256:727b4b9429a443af","schema_hash":"sha256:05005c02d9cffac9","created_at":"2026-09-28T20:30:04.116Z","global_importance":8,"audience_relevance":10,"importance_components":{"tickerTier":"small-cap","eventGravity":"earnings-date-announcement","informationalContent":"none"}},"durationMs":3451,"modelName":"glm-5.3-flashx"}}